-
Coelenterazine for Interpreting ROS Reporter Signals
2026-08-27
Coelenterazine is a luminescent enzyme substrate for connecting reporter activity with reactive oxygen species chemistry. This article presents an orthogonal assay framework inspired by brain–kidney AVP research, emphasizing signal provenance, controls, and translational limits.
-
Aztreonam Workflows for Gram-Negative Research
2026-08-27
Aztreonam supports more than routine growth-inhibition assays: it can connect Gram-negative resistance phenotyping with bone marrow and hepatic drug-metabolism research. This workflow-focused guide covers preparation, assay design, interpretation, and troubleshooting while keeping the evidence boundaries clear.
-
BHQ: From SERCA Mechanism to Translation
2026-08-26
2,5-di-tert-butylbenzene-1,4-diol (BHQ) offers a mechanistic route from SERCA inhibition and calcium-store depletion to ER stress and hematopoietic stem cell mobilization. This thought-leadership guide connects calcium biology with translational study design while defining the compound’s opportunities, controls, and limitations.
-
(S)-Mephenytoin in Human CYP2C19 Translation
2026-08-26
Translational pharmacokinetics requires more than a clean enzyme assay: it requires a mechanistic bridge from catalytic activity to intestinal absorption, metabolism, and interindividual variability. This article positions (S)-Mephenytoin as a defined CYP2C19 substrate for building that bridge, then shows how recombinant systems, human pluripotent stem cell-derived intestinal organoids, and orthogonal analytical controls can be combined into a more decision-ready workflow.
-
URB597 (KDS-4103): Selective FAAH Inhibition
2026-08-25
URB597, also called KDS-4103, is a potent and selective FAAH inhibitor for experimental endocannabinoid research. It increases anandamide availability by blocking FAAH activity, with reported subnanomolar-to-low-nanomolar potency in neuronal systems and rapid in vivo FAAH inhibition in rats.
-
hiPSC Intestinal Organoids for Pharmacokinetic Studies
2026-08-25
Saito and colleagues established a direct three-dimensional culture strategy for generating expandable intestinal organoids from human induced pluripotent stem cells. The organoids could be propagated, cryopreserved, and converted into two-dimensional intestinal epithelial monolayers containing metabolically active enterocytes, supporting more human-relevant pharmacokinetic studies.
-
Tianhuang Formula Targets RAGE/POMC in Metabolism
2026-08-24
This pre-proof study identifies RAGE as a central nervous system target of berberine within Tianhuang Formula and links RAGE/POMC signaling to hypothalamic neuronal apoptosis, autophagy, and glucolipid regulation. Its integrated computational, cellular, and mouse-model design provides a mechanistic framework for testing how neuronal homeostasis contributes to metabolic disease, while broader applications to neurodegeneration remain preliminary.
-
SMYD2 Inhibition in Cisplatin-Induced Renal Fibrosis
2026-08-24
The 2023 reference study identifies SMYD2 as a pharmacologically tractable regulator of cisplatin-induced chronic kidney disease, linking its inhibition to reduced renal fibrosis, inflammation, and epithelial–mesenchymal transition. Using AZ505 and LLY507 in animal and tubular epithelial-cell models, the authors connect these effects with altered Smad3, STAT3, and Smad7 signaling, while also defining important limits for translation.
-
Dimethyloxalylglycine (DMOG) Protocol Guide
2026-08-23
Dimethyloxalylglycine (DMOG), SKU A4506, provides a practical way to investigate hypoxia-inducible factor stabilization and related oxygen-sensing responses under normoxic culture conditions. It is intended for controlled in vitro and preclinical in vivo research, not for diagnostic, therapeutic, or medical use.
-
Mianserin HCl–Cyclodextrin Complexation
2026-08-22
The reference study shows that methylated β-cyclodextrin forms measurable host–guest complexes with mianserin hydrochloride but does not reduce its cytotoxicity in B14 cells. Its combined calorimetric, spectroscopic, mass-spectrometric, docking, and cell-based approach demonstrates why improved solubility should not be interpreted as improved biological safety.
-
Tamoxifen Workflows for CreER and Cancer Research
2026-08-22
Tamoxifen is a versatile selective estrogen receptor modulator for conditional genetics, breast cancer research, and immune-oncology assays. This guide connects practical formulation and assay design with a recent study showing that tamoxifen can improve radiation responses by reprogramming tumor-associated macrophages.
-
Spermine Tetrahydrochloride in Translational Biology
2026-08-21
Spermine tetrahydrochloride is more than a polyamine additive: its charge-driven behavior connects membrane stabilization, protein crystallization, and polymer nanoparticle engineering. This thought-leadership article explains how translational researchers can use the reagent strategically, interpret the DDX3 structural biology precedent, and avoid overextending evidence into NMDA receptor or therapeutic claims.
-
Cefazedone (Refosporen) Research Workflows
2026-08-20
Cefazedone (Refosporen) supports reproducible broth-dilution, MIC, and time-dependent PK/PD workflows spanning Gram-positive and Gram-negative bacterial infections. This guide translates its solubility limits, exposure benchmarks, and clinical pharmacodynamic evidence into practical assay design and troubleshooting decisions.
-
EZ Cap™ Cas9 mRNA (m1Ψ) Workflow
2026-08-20
Build transient CRISPR-Cas9 experiments around Cap1-capped, m1Ψ-modified Cas9 mRNA for responsive editing in mammalian cells. This practical guide connects RNA handling, delivery, specificity testing, and the reference study’s mRNA-export insight to help distinguish poor delivery from excessive Cas9 exposure.
-
Tubastatin A: HDAC6 Inhibitor Workflows
2026-08-19
Tubastatin A links selective HDAC6 inhibition with microtubule stabilization, inflammatory control, and programmed-cell-death analysis. This practical guide translates porcine cardiac-arrest evidence into adaptable workflows for cancer biology, inflammation, neuroprotection, and cell-based mechanism studies.